Klinikum rechts der Isar

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Frontline Asciminib Combination in Chronic Phase CML	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 2	2026-08-18	NCT03906292
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)	Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss, Unilateral, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease	Active, not recruiting	Phase 2	2026-01-16	NCT05776459
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Active, not recruiting	Phase 3	2025-09-30	NCT05181592
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Not applicable	2024-03-21	NCT02474641

Clinical trials